Company Profiles

driven by the PitchBook Platform

EBR Systems

EBR Systems
2003 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$50M LATEST DEAL AMOUNT
12 INVESTORS
Description

Developer of an implantable pacemaker designed for wireless tissue stimulation intended to treat heart failure. The company's system, WiSE CRT, uses a proprietary wireless technology to deliver pacing stimulation directly to the inside of the left ventricle of the heart, providing cardiologists with an approach that is designed to overcome limitations of existing CRT (Cardiac Resynchronization Therapy) systems that deliver pacing stimulation to the outside of the left ventricle.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
480 Oakmead Parkway
Sunnyvale, CA 94085
United States

+1 (408) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore EBR Systems’s full profile, request a free trial.

EBR Systems Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 30-Oct-2017 $50M 00000 0000 Completed Clinical Trials - General
7. Later Stage VC (Series E) 06-May-2015 000.00 00000 000.00 Completed Generating Revenue
6. Debt - General 15-Mar-2013 00.000 0000 Completed Generating Revenue
5. Debt - General 25-Jun-2012 00.000 000.00 Completed Generating Revenue
4. Later Stage VC (Series D1) 28-Jan-2011 000 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 28-Jul-2008 0000 000.00 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 05-Dec-2005 $21M $27.4M 000.00 Completed Startup
1. Early Stage VC (Series A) 09-May-2003 $6.37M $6.37M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

EBR Systems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series E 00,000,000 00.000000 00.00 00 00 00 00 00.000
Series D1 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Series C 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 6,434,025 $0.000100 $0.2 $2.44 $2.44 1x $1.95 9.9%
Series A 2,478,077 $0.000100 $0.08 $1 $1 1x $0.92 3.33%
To view this company’s complete Cap Table, request access »

EBR Systems Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Brandon Capital Partners Venture Capital Minority 000 0000 000000 0
M. H. Carnegie Venture Capital Minority 000 0000 000000 0
Pipeline Capital Partners Venture Capital Minority 000 0000 000000 0
Ascension Ventures Growth/Expansion Minority 000 0000 000000 0
Emergent Medical Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

EBR Systems Executive Team (5)

Name Title Board
Seat
Contact
Info
Allan Will Chairman, President & Chief Executive Officer
Richard Riley Co-Founder, Director & Chief Operating Officer
Parker Willis Chief Technology Officer
Mark Schwartz Vice President of Clinical and Regulatory Affairs

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

EBR Systems Board Members (7)

Name Representing Role Since Contact
Info
Allan Will EBR Systems Chairman, President & Chief Executive Officer 000 0000
Chris Nave Ph.D Brandon Capital Partners Board Member 000 0000
David Stassen Split Rock Partners Board Member 000 0000
Leighton Read MD Brandon Capital Partners Board Member 000 0000
Trevor Moody M. H. Carnegie Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 7 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com